Personalised dosing of vancomycin: A prospective and retrospective comparative quasi-experimental study.
Luqman ValiDavid R JenkinsRakesh VajaHussain MullaPublished in: British journal of clinical pharmacology (2020)
Bedside Bayesian-guided personalised dosing of vancomycin increases the proportion of patients achieving target AUC24 and the %TTR.